NEW YORK, Aug. 30 – Lion Bioscience of Heidelberg, Germany, said Thursday that it had licensed its SRS platform to Genomics Collaborative of Cambridge, Mass.

The companies said the SRS platform would allow users to access GCI's databases of patient clinical and sample information as well as public biological data sources via one portal. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.